drugset / Trial / NCT05153395

Impact of Intranasal Insulin on Sympathetic Activity and Cerebral Vasodilation

NCT05153395

Phase 0 Suspended 65 enrolled University of Missouri-Columbia
Non-randomizedParallel-groupOpen-labelBasic science

Summary

The purpose of this project is to examine the impact of increases in brain insulin on sympathetic nervous system activity, as well as peripheral and cerebral blood flow in humans.

Timeline

Start
2021-12-01
Primary completion
2027-06
Completion
2027-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic 160 iu Intranasal